Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-01-26

FDA Approved: IMIQUIMOD — Original Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

The FDA approved Sun Pharmaceutical's Imiquimod as an Original Application (generic) product. It covers actinic keratosis, superficial basal cell carcinoma, and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Imiquimod (imiquimod)

Snippet

ORIG AP for IMIQUIMOD (IMIQUIMOD)